We are live on
!
Find out more
Ken Fisher Fisher Asset Management
AUM
$295B
1-Year Est. Return
32.61%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Fund
S&P 500
1 Year Est. Return
+32.61%
AUM
$295B
AUM Growth
+$1.9B
(+0.65%)
Holding
1,133
Top Buys
| 1 | +$1.88B | |
| 2 | +$1.41B | |
| 3 | +$1.17B | |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| 1 | +$1.74B | |
| 2 | +$1.21B | |
| 3 | +$1.06B | |
| 4 |
Stryker
SYK
|
+$955M |
| 5 |
Boston Scientific
BSX
|
+$695M |
Sector Composition
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
ResMed
RMD
$28.1B
| $12.1M | ﹤0.01% |
54,106
-12,866
|
|
||
377
iShares Core MSCI Europe ETF
IEUR
$8.57B
| $12.1M | ﹤0.01% |
172,138
-7,755
|
|
||
378
Medtronic
MDT
$103B
| $12.1M | ﹤0.01% |
139,339
-85,662
|
|
||
379
Associated Banc-Corp
ASB
$5.54B
| $12M | ﹤0.01% |
465,188
+107,068
|
|
||
380
Insulet
PODD
$10.3B
| $12M | ﹤0.01% |
57,208
+4,473
|
|
||
381
Outfront Media
OUT
$5.52B
| $11.9M | ﹤0.01% |
447,352
+13,519
|
|
||
382
DexCom
DXCM
$28.6B
| $11.8M | ﹤0.01% |
188,645
-41,768
|
|
||
383
Southern Company
SO
$106B
| $11.8M | ﹤0.01% |
122,639
+3,504
|
|
||
|
CURB
384
Curbline Properties
CURB
$3.23B
| $11.7M | ﹤0.01% |
455,496
+8,602
|
|
||
385
Renasant Corp
RNST
$3.89B
| $11.5M | ﹤0.01% |
318,000
-26,721
|
|
||
386
Vanguard Long-Term Treasury ETF
VGLT
$10.4B
| $11.2M | ﹤0.01% |
202,959
-28,090
|
|
||
387
Arcosa
ACA
$6.31B
| $11.1M | ﹤0.01% |
104,924
-2,529
|
|
||
388
State Street SPDR S&P 500 ETF Trust
SPY
$792B
| $10.8M | ﹤0.01% |
16,646
-703
|
|
||
389
Sunstone Hotel Investors
SHO
$2.19B
| $10.8M | ﹤0.01% |
1,197,071
-37,386
|
|
||
390
The Greenbrier Companies
GBX
$1.5B
| $10.7M | ﹤0.01% |
203,511
-10,651
|
|
||
391
Ionis Pharmaceuticals
IONS
$12.2B
| $10.6M | ﹤0.01% |
141,544
-71
|
|
||
392
Incyte
INCY
$20.4B
| $10.6M | ﹤0.01% |
112,746
+31,572
|
|
||
393
Edwards Lifesciences
EW
$49.7B
| $10.6M | ﹤0.01% |
132,199
-13,446
|
|
||
394
Cousins Properties
CUZ
$4.72B
| $10.5M | ﹤0.01% |
465,898
-20,932
|
|
||
395
Service Corp International
SCI
$10.2B
| $10.5M | ﹤0.01% |
127,093
-3,904
|
|
||
396
Qualys
QLYS
$4B
| $10.2M | ﹤0.01% |
116,182
-2,561
|
|
||
397
Steven Madden
SHOO
$3.32B
| $10.2M | ﹤0.01% |
300,000
-26,014
|
|
||
398
Nuvalent
NUVL
$9.76B
| $9.99M | ﹤0.01% |
97,518
-3,188
|
|
||
399
Yum! Brands
YUM
$42.6B
| $9.6M | ﹤0.01% |
61,714
+6,043
|
|
||
400
Park Hotels & Resorts
PK
$2.9B
| $9.52M | ﹤0.01% |
904,247
-123,776
|
|